APO Research
Talk to an analyst

APO RESEARCH · REPORT

Histone Deacetylase 1

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Histone Deacetylase 1 Market Analysis and Forecast 2026-2032

19 December 2025196 pages

Choose your research edition.

Industry ResearchHistone Deacetylase 1 Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Histone Deacetylase 1 Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Histone Deacetylase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Histone Deacetylase 1 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Histone Deacetylase 1 Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Histone Deacetylase 1 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Histone Deacetylase 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Histone Deacetylase 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Histone Deacetylase 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Histone Deacetylase 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Histone Deacetylase 1 include 4SC AG, Acetylon Pharmaceuticals, Inc., Chipscreen Biosciences Ltd, Curis, Inc., HitGen LTD, IRBM Science Park SpA, Italfarmaco S.p.A., MEI Pharma, Inc. and Mirati Therapeutics Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Histone Deacetylase 1, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Histone Deacetylase 1, also provides the sales of main regions and countries. Of the upcoming market potential for Histone Deacetylase 1, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Histone Deacetylase 1 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Histone Deacetylase 1 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Histone Deacetylase 1 sales, projected growth trends, production technology, application and end-user industry.

Histone Deacetylase 1 Segment by Company

4SC AG

Acetylon Pharmaceuticals, Inc.

Chipscreen Biosciences Ltd

Curis, Inc.

HitGen LTD

IRBM Science Park SpA

Italfarmaco S.p.A.

MEI Pharma, Inc.

Mirati Therapeutics Inc.

Oncolys BioPharma Inc.

Sigma-Tau S.p.A.

Syndax Pharmaceuticals, Inc.

TetraLogic Pharmaceuticals

GlaxoSmithKline Plc

Merck & Co., Inc.

Histone Deacetylase 1 Segment by Type

ST-3595

RCY-1305

HG-3001

CS-3158

ACY-957

Others

Histone Deacetylase 1 Segment by Application

Myelofibrosis

Skin Cancer

Neurology

Alopecia

Endometrial Cancer

Others

Histone Deacetylase 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histone Deacetylase 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Histone Deacetylase 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histone Deacetylase 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Histone Deacetylase 1 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Histone Deacetylase 1 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Histone Deacetylase 1 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Histone Deacetylase 1 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ST-3595 Major Manufacturers Table 3. RCY-1305 Major Manufacturers Table 4. HG-3001 Major Manufacturers Table 5. CS-3158 Major Manufacturers Table 6. ACY-957 Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Histone Deacetylase 1 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Myelofibrosis Major Manufacturers Table 10. Skin Cancer Major Manufacturers Table 11. Neurology Major Manufacturers Table 12. Alopecia Major Manufacturers Table 13. Endometrial Cancer Major Manufacturers Table 14. Others Major Manufacturers Table 15. Histone Deacetylase 1 Industry Trends Table 16. Histone Deacetylase 1 Industry Drivers Table 17. Histone Deacetylase 1 Industry Opportunities and Challenges Table 18. Histone Deacetylase 1 Industry Restraints Table 19. Global Histone Deacetylase 1 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Histone Deacetylase 1 Revenue by Region (2021-2026) & (US$ Million) Table 21. Global Histone Deacetylase 1 Revenue by Region (2027-2032) & (US$ Million) Table 22. Global Histone Deacetylase 1 Revenue Market Share by Region (2021-2026) Table 23. Global Histone Deacetylase 1 Revenue Market Share by Region (2027-2032) Table 24. Global Histone Deacetylase 1 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 25. Global Histone Deacetylase 1 Sales by Region (2021-2026) & (K Units) Table 26. Global Histone Deacetylase 1 Sales by Region (2027-2032) & (K Units) Table 27. Global Histone Deacetylase 1 Sales Market Share by Region (2021-2026) Table 28. Global Histone Deacetylase 1 Sales Market Share by Region (2027-2032) Table 29. Global Histone Deacetylase 1 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Histone Deacetylase 1 Revenue Market Share by Manufacturers (2021-2026) Table 31. Global Histone Deacetylase 1 Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Histone Deacetylase 1 Sales Market Share by Manufacturers (2021-2026) Table 33. Global Histone Deacetylase 1 Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 34. Global Histone Deacetylase 1 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global Histone Deacetylase 1 Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global Histone Deacetylase 1 Manufacturers, Product Type & Application Table 37. Global Histone Deacetylase 1 Manufacturers' Establishment Date Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global Histone Deacetylase 1 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Histone Deacetylase 1 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Histone Deacetylase 1 Revenue by Type (2021-2026) & (US$ Million) Table 42. Global Histone Deacetylase 1 Revenue by Type (2027-2032) & (US$ Million) Table 43. Global Histone Deacetylase 1 Revenue Market Share by Type (2021-2026) Table 44. Global Histone Deacetylase 1 Revenue Market Share by Type (2027-2032) Table 45. Global Histone Deacetylase 1 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 46. Global Histone Deacetylase 1 Sales by Type (2021-2026) & (K Units) Table 47. Global Histone Deacetylase 1 Sales by Type (2027-2032) & (K Units) Table 48. Global Histone Deacetylase 1 Sales Market Share by Type (2021-2026) Table 49. Global Histone Deacetylase 1 Sales Market Share by Type (2027-2032) Table 50. Global Histone Deacetylase 1 Price by Type (2021-2026) & (US$/Unit) Table 51. Global Histone Deacetylase 1 Price by Type (2027-2032) & (US$/Unit) Table 52. Global Histone Deacetylase 1 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Histone Deacetylase 1 Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Histone Deacetylase 1 Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Histone Deacetylase 1 Revenue Market Share by Application (2021-2026) Table 56. Global Histone Deacetylase 1 Revenue Market Share by Application (2027-2032) Table 57. Global Histone Deacetylase 1 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 58. Global Histone Deacetylase 1 Sales by Application (2021-2026) & (K Units) Table 59. Global Histone Deacetylase 1 Sales by Application (2027-2032) & (K Units) Table 60. Global Histone Deacetylase 1 Sales Market Share by Application (2021-2026) Table 61. Global Histone Deacetylase 1 Sales Market Share by Application (2027-2032) Table 62. Global Histone Deacetylase 1 Price by Application (2021-2026) & (US$/Unit) Table 63. Global Histone Deacetylase 1 Price by Application (2027-2032) & (US$/Unit) Table 64. 4SC AG Company Information Table 65. 4SC AG Business Overview Table 66. 4SC AG Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. 4SC AG Histone Deacetylase 1 Product Portfolio Table 68. 4SC AG Recent Development Table 69. Acetylon Pharmaceuticals, Inc. Company Information Table 70. Acetylon Pharmaceuticals, Inc. Business Overview Table 71. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio Table 73. Acetylon Pharmaceuticals, Inc. Recent Development Table 74. Chipscreen Biosciences Ltd Company Information Table 75. Chipscreen Biosciences Ltd Business Overview Table 76. Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Chipscreen Biosciences Ltd Histone Deacetylase 1 Product Portfolio Table 78. Chipscreen Biosciences Ltd Recent Development Table 79. Curis, Inc. Company Information Table 80. Curis, Inc. Business Overview Table 81. Curis, Inc. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Curis, Inc. Histone Deacetylase 1 Product Portfolio Table 83. Curis, Inc. Recent Development Table 84. HitGen LTD Company Information Table 85. HitGen LTD Business Overview Table 86. HitGen LTD Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. HitGen LTD Histone Deacetylase 1 Product Portfolio Table 88. HitGen LTD Recent Development Table 89. IRBM Science Park SpA Company Information Table 90. IRBM Science Park SpA Business Overview Table 91. IRBM Science Park SpA Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. IRBM Science Park SpA Histone Deacetylase 1 Product Portfolio Table 93. IRBM Science Park SpA Recent Development Table 94. Italfarmaco S.p.A. Company Information Table 95. Italfarmaco S.p.A. Business Overview Table 96. Italfarmaco S.p.A. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Italfarmaco S.p.A. Histone Deacetylase 1 Product Portfolio Table 98. Italfarmaco S.p.A. Recent Development Table 99. MEI Pharma, Inc. Company Information Table 100. MEI Pharma, Inc. Business Overview Table 101. MEI Pharma, Inc. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. MEI Pharma, Inc. Histone Deacetylase 1 Product Portfolio Table 103. MEI Pharma, Inc. Recent Development Table 104. Mirati Therapeutics Inc. Company Information Table 105. Mirati Therapeutics Inc. Business Overview Table 106. Mirati Therapeutics Inc. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Mirati Therapeutics Inc. Histone Deacetylase 1 Product Portfolio Table 108. Mirati Therapeutics Inc. Recent Development Table 109. Oncolys BioPharma Inc. Company Information Table 110. Oncolys BioPharma Inc. Business Overview Table 111. Oncolys BioPharma Inc. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Oncolys BioPharma Inc. Histone Deacetylase 1 Product Portfolio Table 113. Oncolys BioPharma Inc. Recent Development Table 114. Sigma-Tau S.p.A. Company Information Table 115. Sigma-Tau S.p.A. Business Overview Table 116. Sigma-Tau S.p.A. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Sigma-Tau S.p.A. Histone Deacetylase 1 Product Portfolio Table 118. Sigma-Tau S.p.A. Recent Development Table 119. Syndax Pharmaceuticals, Inc. Company Information Table 120. Syndax Pharmaceuticals, Inc. Business Overview Table 121. Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio Table 123. Syndax Pharmaceuticals, Inc. Recent Development Table 124. TetraLogic Pharmaceuticals Company Information Table 125. TetraLogic Pharmaceuticals Business Overview Table 126. TetraLogic Pharmaceuticals Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. TetraLogic Pharmaceuticals Histone Deacetylase 1 Product Portfolio Table 128. TetraLogic Pharmaceuticals Recent Development Table 129. GlaxoSmithKline Plc Company Information Table 130. GlaxoSmithKline Plc Business Overview Table 131. GlaxoSmithKline Plc Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. GlaxoSmithKline Plc Histone Deacetylase 1 Product Portfolio Table 133. GlaxoSmithKline Plc Recent Development Table 134. Merck & Co., Inc. Company Information Table 135. Merck & Co., Inc. Business Overview Table 136. Merck & Co., Inc. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Merck & Co., Inc. Histone Deacetylase 1 Product Portfolio Table 138. Merck & Co., Inc. Recent Development Table 139. North America Histone Deacetylase 1 Revenue by Type (2021-2026) & (US$ Million) Table 140. North America Histone Deacetylase 1 Revenue by Type (2027-2032) & (US$ Million) Table 141. North America Histone Deacetylase 1 Sales by Type (2021-2026) & (K Units) Table 142. North America Histone Deacetylase 1 Sales by Type (2027-2032) & (K Units) Table 143. North America Histone Deacetylase 1 Sales Price by Type (2021-2026) & (US$/Unit) Table 144. North America Histone Deacetylase 1 Sales Price by Type (2027-2032) & (US$/Unit) Table 145. North America Histone Deacetylase 1 Revenue by Application (2021-2026) & (US$ Million) Table 146. North America Histone Deacetylase 1 Revenue by Application (2027-2032) & (US$ Million) Table 147. North America Histone Deacetylase 1 Sales by Application (2021-2026) & (K Units) Table 148. North America Histone Deacetylase 1 Sales by Application (2027-2032) & (K Units) Table 149. North America Histone Deacetylase 1 Sales Price by Application (2021-2026) & (US$/Unit) Table 150. North America Histone Deacetylase 1 Sales Price by Application (2027-2032) & (US$/Unit) Table 151. North America Histone Deacetylase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. North America Histone Deacetylase 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. North America Histone Deacetylase 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. North America Histone Deacetylase 1 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 155. North America Histone Deacetylase 1 Sales by Country (2021-2026) & (K Units) Table 156. North America Histone Deacetylase 1 Sales by Country (2027-2032) & (K Units) Table 157. North America Histone Deacetylase 1 Sales Price by Country (2021-2026) & (US$/Unit) Table 158. North America Histone Deacetylase 1 Sales Price by Country (2027-2032) & (US$/Unit) Table 159. United States Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 160. Canada Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 161. Europe Histone Deacetylase 1 Revenue by Type (2021-2026) & (US$ Million) Table 162. Europe Histone Deacetylase 1 Revenue by Type (2027-2032) & (US$ Million) Table 163. Europe Histone Deacetylase 1 Sales by Type (2021-2026) & (K Units) Table 164. Europe Histone Deacetylase 1 Sales by Type (2027-2032) & (K Units) Table 165. Europe Histone Deacetylase 1 Sales Price by Type (2021-2026) & (US$/Unit) Table 166. Europe Histone Deacetylase 1 Sales Price by Type (2027-2032) & (US$/Unit) Table 167. Europe Histone Deacetylase 1 Revenue by Application (2021-2026) & (US$ Million) Table 168. Europe Histone Deacetylase 1 Revenue by Application (2027-2032) & (US$ Million) Table 169. Europe Histone Deacetylase 1 Sales by Application (2021-2026) & (K Units) Table 170. Europe Histone Deacetylase 1 Sales by Application (2027-2032) & (K Units) Table 171. Europe Histone Deacetylase 1 Sales Price by Application (2021-2026) & (US$/Unit) Table 172. Europe Histone Deacetylase 1 Sales Price by Application (2027-2032) & (US$/Unit) Table 173. Europe Histone Deacetylase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Europe Histone Deacetylase 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Europe Histone Deacetylase 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Europe Histone Deacetylase 1 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 177. Europe Histone Deacetylase 1 Sales by Country (2021-2026) & (K Units) Table 178. Europe Histone Deacetylase 1 Sales by Country (2027-2032) & (K Units) Table 179. Europe Histone Deacetylase 1 Sales Price by Country (2021-2026) & (US$/Unit) Table 180. Europe Histone Deacetylase 1 Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Germany Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 182. France Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 183. U.K. Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 184. Italy Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 185. Netherlands Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 186. China Histone Deacetylase 1 Revenue by Type (2021-2026) & (US$ Million) Table 187. China Histone Deacetylase 1 Revenue by Type (2027-2032) & (US$ Million) Table 188. China Histone Deacetylase 1 Sales by Type (2021-2026) & (K Units) Table 189. China Histone Deacetylase 1 Sales by Type (2027-2032) & (K Units) Table 190. China Histone Deacetylase 1 Sales Price by Type (2021-2026) & (US$/Unit) Table 191. China Histone Deacetylase 1 Sales Price by Type (2027-2032) & (US$/Unit) Table 192. China Histone Deacetylase 1 Revenue by Application (2021-2026) & (US$ Million) Table 193. China Histone Deacetylase 1 Revenue by Application (2027-2032) & (US$ Million) Table 194. China Histone Deacetylase 1 Sales by Application (2021-2026) & (K Units) Table 195. China Histone Deacetylase 1 Sales by Application (2027-2032) & (K Units) Table 196. China Histone Deacetylase 1 Sales Price by Application (2021-2026) & (US$/Unit) Table 197. China Histone Deacetylase 1 Sales Price by Application (2027-2032) & (US$/Unit) Table 198. Asia Histone Deacetylase 1 Revenue by Type (2021-2026) & (US$ Million) Table 199. Asia Histone Deacetylase 1 Revenue by Type (2027-2032) & (US$ Million) Table 200. Asia Histone Deacetylase 1 Sales by Type (2021-2026) & (K Units) Table 201. Asia Histone Deacetylase 1 Sales by Type (2027-2032) & (K Units) Table 202. Asia Histone Deacetylase 1 Sales Price by Type (2021-2026) & (US$/Unit) Table 203. Asia Histone Deacetylase 1 Sales Price by Type (2027-2032) & (US$/Unit) Table 204. Asia Histone Deacetylase 1 Revenue by Application (2021-2026) & (US$ Million) Table 205. Asia Histone Deacetylase 1 Revenue by Application (2027-2032) & (US$ Million) Table 206. Asia Histone Deacetylase 1 Sales by Application (2021-2026) & (K Units) Table 207. Asia Histone Deacetylase 1 Sales by Application (2027-2032) & (K Units) Table 208. Asia Histone Deacetylase 1 Sales Price by Application (2021-2026) & (US$/Unit) Table 209. Asia Histone Deacetylase 1 Sales Price by Application (2027-2032) & (US$/Unit) Table 210. Asia Histone Deacetylase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. Asia Histone Deacetylase 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. Asia Histone Deacetylase 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. Asia Histone Deacetylase 1 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 214. Asia Histone Deacetylase 1 Sales by Country (2021-2026) & (K Units) Table 215. Asia Histone Deacetylase 1 Sales by Country (2027-2032) & (K Units) Table 216. Asia Histone Deacetylase 1 Sales Price by Country (2021-2026) & (US$/Unit) Table 217. Asia Histone Deacetylase 1 Sales Price by Country (2027-2032) & (US$/Unit) Table 218. Japan Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 219. South Korea Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 220. India Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 221. Australia Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 222. China Taiwan Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 223. Southeast Asia Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 224. SAMEA Histone Deacetylase 1 Revenue by Type (2021-2026) & (US$ Million) Table 225. SAMEA Histone Deacetylase 1 Revenue by Type (2027-2032) & (US$ Million) Table 226. SAMEA Histone Deacetylase 1 Sales by Type (2021-2026) & (K Units) Table 227. SAMEA Histone Deacetylase 1 Sales by Type (2027-2032) & (K Units) Table 228. SAMEA Histone Deacetylase 1 Sales Price by Type (2021-2026) & (US$/Unit) Table 229. SAMEA Histone Deacetylase 1 Sales Price by Type (2027-2032) & (US$/Unit) Table 230. SAMEA Histone Deacetylase 1 Revenue by Application (2021-2026) & (US$ Million) Table 231. SAMEA Histone Deacetylase 1 Revenue by Application (2027-2032) & (US$ Million) Table 232. SAMEA Histone Deacetylase 1 Sales by Application (2021-2026) & (K Units) Table 233. SAMEA Histone Deacetylase 1 Sales by Application (2027-2032) & (K Units) Table 234. SAMEA Histone Deacetylase 1 Sales Price by Application (2021-2026) & (US$/Unit) Table 235. SAMEA Histone Deacetylase 1 Sales Price by Application (2027-2032) & (US$/Unit) Table 236. SAMEA Histone Deacetylase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 237. SAMEA Histone Deacetylase 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 238. SAMEA Histone Deacetylase 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 239. SAMEA Histone Deacetylase 1 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 240. SAMEA Histone Deacetylase 1 Sales by Country (2021-2026) & (K Units) Table 241. SAMEA Histone Deacetylase 1 Sales by Country (2027-2032) & (K Units) Table 242. SAMEA Histone Deacetylase 1 Sales Price by Country (2021-2026) & (US$/Unit) Table 243. SAMEA Histone Deacetylase 1 Sales Price by Country (2027-2032) & (US$/Unit) Table 244. Brazil Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 245. Argentina Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 246. Chile Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 247. Colombia Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 248. Peru Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 249. Saudi Arabia Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 250. Israel Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 251. UAE Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 252. Turkey Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 253. Iran Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 254. Egypt Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Table 255. Key Raw Materials Table 256. Raw Materials Key Suppliers Table 257. Histone Deacetylase 1 Distributors List Table 258. Histone Deacetylase 1 Customers List Table 259. Research Programs/Design for This Report Table 260. Authors List of This Report Table 261. Secondary Sources Table 262. Primary Sources List of Figures Figure 1. Histone Deacetylase 1 Image Figure 2. Global Histone Deacetylase 1 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Histone Deacetylase 1 Market Size Share 2021 VS 2025 VS 2032 Figure 4. ST-3595 Image Figure 5. RCY-1305 Image Figure 6. HG-3001 Image Figure 7. CS-3158 Image Figure 8. ACY-957 Image Figure 9. Others Image Figure 10. Global Histone Deacetylase 1 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Histone Deacetylase 1 Market Size Share 2021 VS 2025 VS 2032 Figure 12. Myelofibrosis Image Figure 13. Skin Cancer Image Figure 14. Neurology Image Figure 15. Alopecia Image Figure 16. Endometrial Cancer Image Figure 17. Others Image Figure 18. Global Histone Deacetylase 1 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Figure 20. Global Histone Deacetylase 1 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Histone Deacetylase 1 Revenue Market Share by Region: 2025 Versus 2032 Figure 22. Global Histone Deacetylase 1 Revenue Market Share by Region (2021-2032) Figure 23. Global Histone Deacetylase 1 Sales (2021-2032) & (K Units) Figure 24. Global Histone Deacetylase 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 25. Global Histone Deacetylase 1 Sales Market Share by Region (2021-2032) Figure 26. US & Canada & Mexico Histone Deacetylase 1 Sales YoY (2021-2032) & (K Units) Figure 27. Europe Histone Deacetylase 1 Sales YoY (2021-2032) & (K Units) Figure 28. China Histone Deacetylase 1 Sales YoY (2021-2032) & (K Units) Figure 29. Asia (Excluding China) Histone Deacetylase 1 Sales YoY (2021-2032) & (K Units) Figure 30. South America, Middle East and Africa Histone Deacetylase 1 Sales YoY (2021-2032) & (K Units) Figure 31. Global Histone Deacetylase 1 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 32. Global Histone Deacetylase 1 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 33. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 34. Global Histone Deacetylase 1 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Histone Deacetylase 1 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Histone Deacetylase 1 Revenue Market Share by Type (2021-2032) Figure 37. Global Histone Deacetylase 1 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Histone Deacetylase 1 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 39. Global Histone Deacetylase 1 Sales Market Share by Type (2021-2032) Figure 40. Global Histone Deacetylase 1 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 41. Global Histone Deacetylase 1 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Histone Deacetylase 1 Revenue Market Share by Application (2021-2032) Figure 43. Global Histone Deacetylase 1 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 44. Global Histone Deacetylase 1 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 45. Global Histone Deacetylase 1 Sales Market Share by Application (2021-2032) Figure 46. North America Histone Deacetylase 1 Revenue Share by Type (2021-2032) Figure 47. North America Histone Deacetylase 1 Sales Share by Type (2021-2032) Figure 48. North America Histone Deacetylase 1 Revenue Share by Application (2021-2032) Figure 49. North America Histone Deacetylase 1 Sales Share by Application (2021-2032) Figure 50. North America Histone Deacetylase 1 Revenue Share by Country (2021-2032) Figure 51. North America Histone Deacetylase 1 Sales Share by Country (2021-2032) Figure 52. Europe Histone Deacetylase 1 Revenue Share by Type (2021-2032) Figure 53. Europe Histone Deacetylase 1 Sales Share by Type (2021-2032) Figure 54. Europe Histone Deacetylase 1 Revenue Share by Application (2021-2032) Figure 55. Europe Histone Deacetylase 1 Sales Share by Application (2021-2032) Figure 56. Europe Histone Deacetylase 1 Revenue Share by Country (2021-2032) Figure 57. Europe Histone Deacetylase 1 Sales Share by Country (2021-2032) Figure 58. China Histone Deacetylase 1 Revenue Share by Type (2021-2032) Figure 59. China Histone Deacetylase 1 Sales Share by Type (2021-2032) Figure 60. China Histone Deacetylase 1 Revenue Share by Application (2021-2032) Figure 61. China Histone Deacetylase 1 Sales Share by Application (2021-2032) Figure 62. Asia Histone Deacetylase 1 Revenue Share by Type (2021-2032) Figure 63. Asia Histone Deacetylase 1 Sales Share by Type (2021-2032) Figure 64. Asia Histone Deacetylase 1 Revenue Share by Application (2021-2032) Figure 65. Asia Histone Deacetylase 1 Sales Share by Application (2021-2032) Figure 66. Asia Histone Deacetylase 1 Revenue Share by Country (2021-2032) Figure 67. Asia Histone Deacetylase 1 Sales Share by Country (2021-2032) Figure 68. SAMEA Histone Deacetylase 1 Revenue Share by Type (2021-2032) Figure 69. SAMEA Histone Deacetylase 1 Sales Share by Type (2021-2032) Figure 70. SAMEA Histone Deacetylase 1 Revenue Share by Application (2021-2032) Figure 71. SAMEA Histone Deacetylase 1 Sales Share by Application (2021-2032) Figure 72. SAMEA Histone Deacetylase 1 Revenue Share by Country (2021-2032) Figure 73. SAMEA Histone Deacetylase 1 Sales Share by Country (2021-2032) Figure 74. Histone Deacetylase 1 Value Chain Figure 75. Manufacturing Cost Structure Figure 76. Histone Deacetylase 1 Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • ST-3595
  • RCY-1305
  • HG-3001
  • CS-3158
  • ACY-957
  • Others
Applications
  • Myelofibrosis
  • Skin Cancer
  • Neurology
  • Alopecia
  • Endometrial Cancer
  • Others
Companies covered
  • 4SC AG
  • Acetylon Pharmaceuticals, Inc.
  • Chipscreen Biosciences Ltd
  • Curis, Inc.
  • HitGen LTD
  • IRBM Science Park SpA
  • Italfarmaco S.p.A.
  • MEI Pharma, Inc.
  • Mirati Therapeutics Inc.
  • Oncolys BioPharma Inc.
  • Sigma-Tau S.p.A.
  • Syndax Pharmaceuticals, Inc.
  • TetraLogic Pharmaceuticals
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Histone Deacetylase 1 Market by Type
  3. 1.2.1 Global Histone Deacetylase 1 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ST-3595
  5. 1.2.3 RCY-1305
  6. 1.2.4 HG-3001
  7. 1.2.5 CS-3158
  8. 1.2.6 ACY-957
  9. 1.2.7 Others
  10. 1.3 Histone Deacetylase 1 Market by Application
  11. 1.3.1 Global Histone Deacetylase 1 Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Myelofibrosis
  13. 1.3.3 Skin Cancer
  14. 1.3.4 Neurology
  15. 1.3.5 Alopecia
  16. 1.3.6 Endometrial Cancer
  17. 1.3.7 Others
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Histone Deacetylase 1 Market Dynamics
  1. 2.1 Histone Deacetylase 1 Industry Trends
  2. 2.2 Histone Deacetylase 1 Industry Drivers
  3. 2.3 Histone Deacetylase 1 Industry Opportunities and Challenges
  4. 2.4 Histone Deacetylase 1 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Histone Deacetylase 1 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Histone Deacetylase 1 Revenue by Region
  3. 3.2.1 Global Histone Deacetylase 1 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Histone Deacetylase 1 Revenue by Region (2021-2026)
  5. 3.2.3 Global Histone Deacetylase 1 Revenue by Region (2027-2032)
  6. 3.2.4 Global Histone Deacetylase 1 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Histone Deacetylase 1 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Histone Deacetylase 1 Sales by Region
  9. 3.4.1 Global Histone Deacetylase 1 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Histone Deacetylase 1 Sales by Region (2021-2026)
  11. 3.4.3 Global Histone Deacetylase 1 Sales by Region (2027-2032)
  12. 3.4.4 Global Histone Deacetylase 1 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Histone Deacetylase 1 Revenue by Manufacturers
  2. 4.1.1 Global Histone Deacetylase 1 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Histone Deacetylase 1 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Histone Deacetylase 1 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Histone Deacetylase 1 Sales by Manufacturers
  6. 4.2.1 Global Histone Deacetylase 1 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Histone Deacetylase 1 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Histone Deacetylase 1 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Histone Deacetylase 1 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Histone Deacetylase 1 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Histone Deacetylase 1 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Histone Deacetylase 1 Manufacturers, Product Type & Application
  13. 4.7 Global Histone Deacetylase 1 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Histone Deacetylase 1 Market CR5 and HHI
  16. 4.8.2 2025 Histone Deacetylase 1 Tier 1, Tier 2, and Tier 3
5 Histone Deacetylase 1 Market by Type
  1. 5.1 Global Histone Deacetylase 1 Revenue by Type
  2. 5.1.1 Global Histone Deacetylase 1 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Histone Deacetylase 1 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Histone Deacetylase 1 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Histone Deacetylase 1 Sales by Type
  6. 5.2.1 Global Histone Deacetylase 1 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Histone Deacetylase 1 Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Histone Deacetylase 1 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Histone Deacetylase 1 Price by Type
6 Histone Deacetylase 1 Market by Application
  1. 6.1 Global Histone Deacetylase 1 Revenue by Application
  2. 6.1.1 Global Histone Deacetylase 1 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Histone Deacetylase 1 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Histone Deacetylase 1 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Histone Deacetylase 1 Sales by Application
  6. 6.2.1 Global Histone Deacetylase 1 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Histone Deacetylase 1 Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Histone Deacetylase 1 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Histone Deacetylase 1 Price by Application
7 Company Profiles
  1. 7.1 4SC AG
  2. 7.1.1 4SC AG Company Information
  3. 7.1.2 4SC AG Business Overview
  4. 7.1.3 4SC AG Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 4SC AG Histone Deacetylase 1 Product Portfolio
  6. 7.1.5 4SC AG Recent Developments
  7. 7.2 Acetylon Pharmaceuticals, Inc.
  8. 7.2.1 Acetylon Pharmaceuticals, Inc. Company Information
  9. 7.2.2 Acetylon Pharmaceuticals, Inc. Business Overview
  10. 7.2.3 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio
  12. 7.2.5 Acetylon Pharmaceuticals, Inc. Recent Developments
  13. 7.3 Chipscreen Biosciences Ltd
  14. 7.3.1 Chipscreen Biosciences Ltd Company Information
  15. 7.3.2 Chipscreen Biosciences Ltd Business Overview
  16. 7.3.3 Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Chipscreen Biosciences Ltd Histone Deacetylase 1 Product Portfolio
  18. 7.3.5 Chipscreen Biosciences Ltd Recent Developments
  19. 7.4 Curis, Inc.
  20. 7.4.1 Curis, Inc. Company Information
  21. 7.4.2 Curis, Inc. Business Overview
  22. 7.4.3 Curis, Inc. Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Curis, Inc. Histone Deacetylase 1 Product Portfolio
  24. 7.4.5 Curis, Inc. Recent Developments
  25. 7.5 HitGen LTD
  26. 7.5.1 HitGen LTD Company Information
  27. 7.5.2 HitGen LTD Business Overview
  28. 7.5.3 HitGen LTD Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 HitGen LTD Histone Deacetylase 1 Product Portfolio
  30. 7.5.5 HitGen LTD Recent Developments
  31. 7.6 IRBM Science Park SpA
  32. 7.6.1 IRBM Science Park SpA Company Information
  33. 7.6.2 IRBM Science Park SpA Business Overview
  34. 7.6.3 IRBM Science Park SpA Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 IRBM Science Park SpA Histone Deacetylase 1 Product Portfolio
  36. 7.6.5 IRBM Science Park SpA Recent Developments
  37. 7.7 Italfarmaco S.p.A.
  38. 7.7.1 Italfarmaco S.p.A. Company Information
  39. 7.7.2 Italfarmaco S.p.A. Business Overview
  40. 7.7.3 Italfarmaco S.p.A. Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Italfarmaco S.p.A. Histone Deacetylase 1 Product Portfolio
  42. 7.7.5 Italfarmaco S.p.A. Recent Developments
  43. 7.8 MEI Pharma, Inc.
  44. 7.8.1 MEI Pharma, Inc. Company Information
  45. 7.8.2 MEI Pharma, Inc. Business Overview
  46. 7.8.3 MEI Pharma, Inc. Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 MEI Pharma, Inc. Histone Deacetylase 1 Product Portfolio
  48. 7.8.5 MEI Pharma, Inc. Recent Developments
  49. 7.9 Mirati Therapeutics Inc.
  50. 7.9.1 Mirati Therapeutics Inc. Company Information
  51. 7.9.2 Mirati Therapeutics Inc. Business Overview
  52. 7.9.3 Mirati Therapeutics Inc. Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Mirati Therapeutics Inc. Histone Deacetylase 1 Product Portfolio
  54. 7.9.5 Mirati Therapeutics Inc. Recent Developments
  55. 7.10 Oncolys BioPharma Inc.
  56. 7.10.1 Oncolys BioPharma Inc. Company Information
  57. 7.10.2 Oncolys BioPharma Inc. Business Overview
  58. 7.10.3 Oncolys BioPharma Inc. Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Oncolys BioPharma Inc. Histone Deacetylase 1 Product Portfolio
  60. 7.10.5 Oncolys BioPharma Inc. Recent Developments
  61. 7.11 Sigma-Tau S.p.A.
  62. 7.11.1 Sigma-Tau S.p.A. Company Information
  63. 7.11.2 Sigma-Tau S.p.A. Business Overview
  64. 7.11.3 Sigma-Tau S.p.A. Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sigma-Tau S.p.A. Histone Deacetylase 1 Product Portfolio
  66. 7.11.5 Sigma-Tau S.p.A. Recent Developments
  67. 7.12 Syndax Pharmaceuticals, Inc.
  68. 7.12.1 Syndax Pharmaceuticals, Inc. Company Information
  69. 7.12.2 Syndax Pharmaceuticals, Inc. Business Overview
  70. 7.12.3 Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio
  72. 7.12.5 Syndax Pharmaceuticals, Inc. Recent Developments
  73. 7.13 TetraLogic Pharmaceuticals
  74. 7.13.1 TetraLogic Pharmaceuticals Company Information
  75. 7.13.2 TetraLogic Pharmaceuticals Business Overview
  76. 7.13.3 TetraLogic Pharmaceuticals Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 TetraLogic Pharmaceuticals Histone Deacetylase 1 Product Portfolio
  78. 7.13.5 TetraLogic Pharmaceuticals Recent Developments
  79. 7.14 GlaxoSmithKline Plc
  80. 7.14.1 GlaxoSmithKline Plc Company Information
  81. 7.14.2 GlaxoSmithKline Plc Business Overview
  82. 7.14.3 GlaxoSmithKline Plc Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 GlaxoSmithKline Plc Histone Deacetylase 1 Product Portfolio
  84. 7.14.5 GlaxoSmithKline Plc Recent Developments
  85. 7.15 Merck & Co., Inc.
  86. 7.15.1 Merck & Co., Inc. Company Information
  87. 7.15.2 Merck & Co., Inc. Business Overview
  88. 7.15.3 Merck & Co., Inc. Histone Deacetylase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Merck & Co., Inc. Histone Deacetylase 1 Product Portfolio
  90. 7.15.5 Merck & Co., Inc. Recent Developments
8 North America
  1. 8.1 North America Histone Deacetylase 1 Market Size by Type
  2. 8.1.1 North America Histone Deacetylase 1 Revenue by Type (2021-2032)
  3. 8.1.2 North America Histone Deacetylase 1 Sales by Type (2021-2032)
  4. 8.1.3 North America Histone Deacetylase 1 Price by Type (2021-2032)
  5. 8.2 North America Histone Deacetylase 1 Market Size by Application
  6. 8.2.1 North America Histone Deacetylase 1 Revenue by Application (2021-2032)
  7. 8.2.2 North America Histone Deacetylase 1 Sales by Application (2021-2032)
  8. 8.2.3 North America Histone Deacetylase 1 Price by Application (2021-2032)
  9. 8.3 North America Histone Deacetylase 1 Market Size by Country
  10. 8.3.1 North America Histone Deacetylase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Histone Deacetylase 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Histone Deacetylase 1 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Histone Deacetylase 1 Market Size by Type
  2. 9.1.1 Europe Histone Deacetylase 1 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Histone Deacetylase 1 Sales by Type (2021-2032)
  4. 9.1.3 Europe Histone Deacetylase 1 Price by Type (2021-2032)
  5. 9.2 Europe Histone Deacetylase 1 Market Size by Application
  6. 9.2.1 Europe Histone Deacetylase 1 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Histone Deacetylase 1 Sales by Application (2021-2032)
  8. 9.2.3 Europe Histone Deacetylase 1 Price by Application (2021-2032)
  9. 9.3 Europe Histone Deacetylase 1 Market Size by Country
  10. 9.3.1 Europe Histone Deacetylase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Histone Deacetylase 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Histone Deacetylase 1 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Histone Deacetylase 1 Market Size by Type
  2. 10.1.1 China Histone Deacetylase 1 Revenue by Type (2021-2032)
  3. 10.1.2 China Histone Deacetylase 1 Sales by Type (2021-2032)
  4. 10.1.3 China Histone Deacetylase 1 Price by Type (2021-2032)
  5. 10.2 China Histone Deacetylase 1 Market Size by Application
  6. 10.2.1 China Histone Deacetylase 1 Revenue by Application (2021-2032)
  7. 10.2.2 China Histone Deacetylase 1 Sales by Application (2021-2032)
  8. 10.2.3 China Histone Deacetylase 1 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Histone Deacetylase 1 Market Size by Type
  2. 11.1.1 Asia Histone Deacetylase 1 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Histone Deacetylase 1 Sales by Type (2021-2032)
  4. 11.1.3 Asia Histone Deacetylase 1 Price by Type (2021-2032)
  5. 11.2 Asia Histone Deacetylase 1 Market Size by Application
  6. 11.2.1 Asia Histone Deacetylase 1 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Histone Deacetylase 1 Sales by Application (2021-2032)
  8. 11.2.3 Asia Histone Deacetylase 1 Price by Application (2021-2032)
  9. 11.3 Asia Histone Deacetylase 1 Market Size by Country
  10. 11.3.1 Asia Histone Deacetylase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Histone Deacetylase 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Histone Deacetylase 1 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Histone Deacetylase 1 Market Size by Type
  2. 12.1.1 SAMEA Histone Deacetylase 1 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Histone Deacetylase 1 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Histone Deacetylase 1 Price by Type (2021-2032)
  5. 12.2 SAMEA Histone Deacetylase 1 Market Size by Application
  6. 12.2.1 SAMEA Histone Deacetylase 1 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Histone Deacetylase 1 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Histone Deacetylase 1 Price by Application (2021-2032)
  9. 12.3 SAMEA Histone Deacetylase 1 Market Size by Country
  10. 12.3.1 SAMEA Histone Deacetylase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Histone Deacetylase 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Histone Deacetylase 1 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Histone Deacetylase 1 Value Chain Analysis
  2. 13.1.1 Histone Deacetylase 1 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Histone Deacetylase 1 Production Mode & Process
  6. 13.2 Histone Deacetylase 1 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Histone Deacetylase 1 Distributors
  9. 13.2.3 Histone Deacetylase 1 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst